Search Videos and More

Showing 1 - 12 of 94 results

Previous| 1 | 2 | 3 ...8 |Next


Repurposed drug has promising efficacy in non-small cell lung cancer News

Repurposed drug has promising efficacy in non-small cell lung cancer

UTSW-led clinical trial suggests broader use for selinexor in cancers with KRAS mutations
Future of Thoracic Surgery Video

Future of Thoracic Surgery

Inderpal Sarkaria, M.D., Chief of the Division of Thoracic Surgery, shares his optimism for the future of Thoracic Surgery at UT Southwestern.
Director of Simmons Cancer Center, UTSW Pharmacology Chair elected to the National Academy of Medicine News

Director of Simmons Cancer Center, UTSW Pharmacology Chair elected to the National Academy of Medicine

Carlos L. Arteaga, M.D., and David Mangelsdorf, Ph.D., are UTSW’s 23rd and 24th members of the NAM, the most of any institution in Texas
Latino enclaves in U.S. have less accessible health care News

Latino enclaves in U.S. have less accessible health care

Study led by UTSW researcher describes socioeconomic challenges in culturally distinct neighborhoods for fastest-growing ethnic group
UT Southwestern biochemist Zhijian ‘James’ Chen, Ph.D., earns prestigious Lasker Award News

UT Southwestern biochemist Zhijian ‘James’ Chen, Ph.D., earns prestigious Lasker Award

Dr. Chen’s discovery of cGAS, which triggers innate immunity, also honored with Germany’s top scientific prize
Pathway tied to cancer-driving genome alterations identified News

Pathway tied to cancer-driving genome alterations identified

Understanding how chromosome shattering occurs could lead to strategies to overcome therapy resistance, UTSW study shows
Widespread disparities exist in treating advanced cancers News

Widespread disparities exist in treating advanced cancers

Likelihood of patients receiving FDA-approved immunotherapies for late-stage kidney and bladder cancers linked to race, socioeconomic factors, facility type
Basic Research: R01s – Drs. Todd Aguilera & You Zhang News

Basic Research: R01s – Drs. Todd Aguilera & You Zhang

Doctor Spotlights
DARTBOARD Clinical Trial News

DARTBOARD Clinical Trial

DARTBOARD (STU2021-0401: A Prospective Randomized Phase II Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer), an innovative, first-of-its-kind clinical trial, is now complete.
Markerless Radiation Erases a Reminder and Improves Breast Cancer Therapy News

Markerless Radiation Erases a Reminder and Improves Breast Cancer Therapy

Breast cancer almost always leaves its mark on patients. Along with surgical scars and changes in breast size and shape, medical tattoos or semi-permanent marker dots and lines were drawn on the patient’s chest to align radiotherapy beams, like checkpoints on a map.
Upon Further RefleXion News

Upon Further RefleXion

The RefleXion X1 radiation treatment platform is the first to integrate PET/CT imaging with a medical linear accelerator. Using a PET signal identifying the tumor while also depicting its biology, RefleXion treats patients with unique biology-guided radiotherapy (BgRT). The UT Southwestern Department of Radiation Oncology is one of a handful of centers worldwide with this treatment capability.
Upgrading HDR Brachytherapy News

Upgrading HDR Brachytherapy

High-dose-rate (HDR) brachytherapy is a procedure where the patient receives a dose from a powerful radioactive source for a few minutes per treatment session, after which the source is removed. The radioactive source, stored in an afterloader unit, travels through special applicators that then deliver the dose to the site of the tumor.

Showing 1 - 12 of 94 results

Previous| 1 | 2 | 3 ...8 |Next